Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
clopidogrel (plavix) (1 trial)
rimabotulinumtoxinB (Myobloc) (1 trial)
ticagrelor (brilinta) (1 trial)
autologous bone marrow derived mesenchymal cells (1 trial)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Ischemia (Phase 4)
Myocardial Ischemia (Phase 4)
Urinary Bladder, Overactive (Phase 4)
Trials (3 total)
Trial APIs (4 total)